Product Name:

JNK3-2


Product Number:

ab-nk197-3

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPKb)) 3

Target Alias: c-Jun N-terminal kinase 3; FLJ12099; FLJ33785; JNK3A; JNK3-alpha-2; Kinase JNK3; MAP kinase p49 3F12; MAPK10; MGC50974; MK10; P493F12; p54bSAPK; PRKM10; Stress-activated protein kinase JNK3; PRKM10; CCDS3613.1; ENSG00000109339

Product Type Specific: Protein kinase pan-specific antibody

Antibody Code: NK197-3

Antibody Target Type: Pan-specific

Protein UniProt: P53779

Protein SigNET: P53779

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human JNK3 (MAPK10) sequence peptide Cat. No.: PE-01AXR90

Antibody Immunogen Sequence: KQVDVSYIAKHYNMSC

Antibody Immunogen Description: Corresponds to amino acid residues K26 to S40; Post-N-terminus

Production Method: Corresponds to amino acid residues K26 to S40; Post-N-terminus

Antibody Modification: Protein kinase pan-specific antibody

Antibody Concentration: 0.1 / 0.16 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human; Mouse

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 48-54 kDa.

Antibody Specificity: Very high

Antibody Cross Reactivity: Possible immunoreactivity on protein dot blots with recombinant human JNK2.

Scientific Background: JNK3 (MAPK10) is a protein-serine/threonine kinase of the CMGC group and MAPK family. Phosphorylation at T221 and Y223, by MAP2K4 and MAP2K7. MAP2K7, increases phosphotransferase activity. MAP2K7 phosphorylates JNK3 on T221 causing a conformational change and a large increase in Vmax. MAP2K4 then phosphorylates Y223 resulting in a further increase in Vmax. Phosphorylation at T131 inhibits phosphotransferase activity. It is inhibited by dual specificity phosphatases, such as DUSP1 and by HDAC9. The near absence of reported somatic mutations in this protein indicates that it may function as a tumour requiring protein (TRP) in many human tumours.